Replies to post #11429 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

The PH3 trial had to be performed for European approvals so I think Synthon is simply trying to kill two birds with one stone.

I agree that the results make many of Teva's claims mute.